Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

287 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Asthma drug use and the development of Churg-Strauss syndrome (CSS).
Harrold LR, Patterson MK, Andrade SE, Dube T, Go AS, Buist AS, Chan KA, Weller PF, Wechsler ME, Yood RA, Davis KJ, Platt R, Walker AM. Harrold LR, et al. Among authors: weller pf. Pharmacoepidemiol Drug Saf. 2007 Jun;16(6):620-6. doi: 10.1002/pds.1353. Pharmacoepidemiol Drug Saf. 2007. PMID: 17192840
Mepolizumab or Placebo for Eosinophilic Granulomatosis with Polyangiitis.
Wechsler ME, Akuthota P, Jayne D, Khoury P, Klion A, Langford CA, Merkel PA, Moosig F, Specks U, Cid MC, Luqmani R, Brown J, Mallett S, Philipson R, Yancey SW, Steinfeld J, Weller PF, Gleich GJ; EGPA Mepolizumab Study Team. Wechsler ME, et al. Among authors: weller pf. N Engl J Med. 2017 May 18;376(20):1921-1932. doi: 10.1056/NEJMoa1702079. N Engl J Med. 2017. PMID: 28514601 Free PMC article. Clinical Trial.
In Reply-Are Eosinophils Needed for Normal Health?
Wechsler ME, Ackerman SJ, Weller PF. Wechsler ME, et al. Among authors: weller pf. Mayo Clin Proc. 2022 Apr;97(4):805-807. doi: 10.1016/j.mayocp.2022.01.037. Mayo Clin Proc. 2022. PMID: 35379426 No abstract available.
Pulmonary Eosinophilic Granulomatosis with Polyangiitis Has IgG4 Plasma Cells and Immunoregulatory Features.
Dong ZM, Lin E, Wechsler ME, Weller PF, Klion AD, Bochner BS, Delker DA, Hazel MW, Fairfax K, Khoury P, Akuthota P, Merkel PA, Dyer AM, Langford C, Specks U, Gleich GJ, Chinchilli VM, Raby B, Yandell M, Clayton F. Dong ZM, et al. Among authors: weller pf. Am J Pathol. 2020 Jul;190(7):1438-1448. doi: 10.1016/j.ajpath.2020.03.005. Epub 2020 Apr 3. Am J Pathol. 2020. PMID: 32251643 Free PMC article.
Approaches to the treatment of hypereosinophilic syndromes: a workshop summary report.
Klion AD, Bochner BS, Gleich GJ, Nutman TB, Rothenberg ME, Simon HU, Wechsler ME, Weller PF; The Hypereosinophilic Syndromes Working Group. Klion AD, et al. Among authors: weller pf. J Allergy Clin Immunol. 2006 Jun;117(6):1292-302. doi: 10.1016/j.jaci.2006.02.042. Epub 2006 May 3. J Allergy Clin Immunol. 2006. PMID: 16750989
Novel targeted therapies for eosinophilic disorders.
Wechsler ME, Fulkerson PC, Bochner BS, Gauvreau GM, Gleich GJ, Henkel T, Kolbeck R, Mathur SK, Ortega H, Patel J, Prussin C, Renzi P, Rothenberg ME, Roufosse F, Simon D, Simon HU, Wardlaw A, Weller PF, Klion AD. Wechsler ME, et al. Among authors: weller pf. J Allergy Clin Immunol. 2012 Sep;130(3):563-71. doi: 10.1016/j.jaci.2012.07.027. J Allergy Clin Immunol. 2012. PMID: 22935585 Free PMC article. Review.
Refining the definition of hypereosinophilic syndrome.
Simon HU, Rothenberg ME, Bochner BS, Weller PF, Wardlaw AJ, Wechsler ME, Rosenwasser LJ, Roufosse F, Gleich GJ, Klion AD. Simon HU, et al. Among authors: weller pf. J Allergy Clin Immunol. 2010 Jul;126(1):45-9. doi: 10.1016/j.jaci.2010.03.042. J Allergy Clin Immunol. 2010. PMID: 20639008 Free PMC article. Review.
287 results